Education
About Us
Working with TipRanks
Follow Us
Sionna Therapeutics, Inc. (SION)
NASDAQ:SION
Total Valuation
Sionna Therapeutics, Inc. has a market cap or net worth of $1.95B. The enterprise value is $1.07B.
Market Cap$1.95B
Enterprise Value$1.07B
Share Statistics
Sionna Therapeutics, Inc. has 44,628,788 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding44,628,788
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Sionna Therapeutics, Inc.’s return on equity (ROE) is 0.38 and return on invested capital (ROIC) is -39.76%.
Return on Equity (ROE)0.38
Return on Assets (ROA)-0.33
Return on Invested Capital (ROIC)-39.76%
Return on Capital Employed (ROCE)-0.40
Revenue Per Employee0.00
Profits Per Employee-1.50M
Employee Count41
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Sionna Therapeutics, Inc. is ―. Sionna Therapeutics, Inc.’s PEG ratio is -0.59.
PE Ratio―
PS Ratio0.00
PB Ratio-6.74
Price to Fair Value-6.74
Price to FCF-20.89
Price to Operating Cash Flow-28.31
PEG Ratio-0.59
Income Statement
In the last 12 months, Sionna Therapeutics, Inc. had revenue of 0.00 and earned -61.69M in profits. Earnings per share was -1.40.
Revenue0.00
Gross Profit-668.00K
Operating Income-70.56M
Pretax Income-61.69M
Net Income-61.69M
EBITDA-69.89M
Earnings Per Share (EPS)-1.40
Cash Flow
In the last 12 months, operating cash flow was -61.45M and capital expenditures -173.00K, giving a free cash flow of -61.65M billion.
Operating Cash Flow-61.45M
Free Cash Flow-61.65M
Free Cash Flow per Share-1.38
Dividends & Yields
Sionna Therapeutics, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.02
52-Week Price Change92.49%
50-Day Moving Average32.75
200-Day Moving Average―
Relative Strength Index (RSI)71.28
Average Volume (3m)311.13K
Important Dates
Sionna Therapeutics, Inc. upcoming earnings date is Mar 19, 2026, Before Open (Confirmed).
Last Earnings DateNov 5, 2025
Next Earnings DateMar 19, 2026
Ex-Dividend Date―
Financial Position
Sionna Therapeutics, Inc. as a current ratio of 14.49, with Debt / Equity ratio of 2.75%
Current Ratio14.49
Quick Ratio14.49
Debt to Market Cap<0.01
Net Debt to EBITDA0.40
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Sionna Therapeutics, Inc. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Sionna Therapeutics, Inc. EV to EBITDA ratio is -15.38, with an EV/FCF ratio of -20.36.
EV to Sales0.00
EV to EBITDA-15.38
EV to Free Cash Flow-20.36
EV to Operating Cash Flow-20.37
Balance Sheet
Sionna Therapeutics, Inc. has $248.33M in cash and marketable securities with $8.97M in debt, giving a net cash position of $239.36M billion.
Cash & Marketable Securities$248.33M
Total Debt$8.97M
Net Cash$239.36M
Net Cash Per Share$5.36
Tangible Book Value Per Share-$3.71
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Sionna Therapeutics, Inc. is $46.20, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$46.20
Price Target Upside5.72% Upside
Analyst ConsensusModerate Buy
Analyst Count6
Revenue Growth Forecast―
EPS Growth Forecast―